富士製薬工業(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 医薬品 | 4554/E00975 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2016/11/25 | 日証協 | 86,900株 | +4.83% | 5,200株 | +6.12% | 132,179株 | -0.53% | 5,400株 | -40.85% |
| 2016/11/18 | 日証協 | 82,900株 | +1.47% | 4,900株 | +53.12% | 132,879株 | -1.63% | 9,129株 | +44.24% |
| 2016/11/11 | 日証協 | 81,700株 | -12.43% | 3,200株 | -62.35% | 135,079株 | -7.09% | 6,329株 | -39.89% |
| 2016/11/04 | 日証協 | 93,300株 | +0.65% | 8,500株 | +80.85% | 145,390株 | -0.75% | 10,529株 | +43.56% |
| 2016/10/28 | 日証協 | 92,700株 | -5.02% | 4,700株 | +193.75% | 146,490株 | -4.12% | 7,334株 | +266.7% |
| 2016/10/21 | 日証協 | 97,600株 | -23.87% | 1,600株 | -85.05% | 152,786株 | -16.09% | 2,000株 | -76.55% |
| 2016/10/14 | 日証協 | 128,200株 | +1.68% | 10,700株 | -84.43% | 182,086株 | +1.4% | 8,530株 | -87.51% |
| 2016/10/07 | 日証協 | 126,080株 | +101.93% | 68,716株 | +125.15% | 179,565株 | +57.27% | 68,309株 | +594.9% |
| 2016/09/30 | 日証協 | 62,436株 | +6.18% | 30,520株 | +475.41% | 114,174株 | -8.35% | 9,830株 | -64.38% |
| 2016/09/23 | 日証協 | 58,804株 | +1.91% | 5,304株 | -72.66% | 124,576株 | +28.06% | 27,600株 | +125.99% |
| 2016/09/16 | 日証協 | 57,700株 | -0.74% | 19,400株 | +168.36% | 97,276株 | -1.28% | 12,213株 | -55.06% |
| 2016/09/09 | 日証協 | 58,129株 | -7.88% | 7,229株 | -63.29% | 98,537株 | +15.75% | 27,174株 | +6676.56% |
| 2016/09/02 | 日証協 | 63,100株 | +4.99% | 19,691株 | +77.4% | 85,129株 | -0.58% | 401株 | -93.89% |
| 2016/08/26 | 日証協 | 60,100株 | -10.7% | 11,100株 | -45.59% | 85,628株 | -9.94% | 6,565株 | +33.73% |
| 2016/08/19 | 日証協 | 67,300株 | +3.49% | 20,400株 | +139.1% | 95,084株 | +2.01% | 4,909株 | -20.02% |
| 2016/08/12 | 日証協 | 65,032株 | -1.72% | 8,532株 | +87.06% | 93,207株 | -4.77% | 6,138株 | +43.81% |
| 2016/08/05 | 日証協 | 66,168株 | +3.17% | 4,561株 | +22.21% | 97,880株 | +2.02% | 4,268株 | +7.56% |
| 2016/07/29 | 日証協 | 64,132株 | +2.12% | 3,732株 | -87.42% | 95,944株 | +1.58% | 3,968株 | -75.04% |
| 2016/07/22 | 日証協 | 62,800株 | +74.93% | 29,668株 | +735.72% | 94,449株 | +17.89% | 15,900株 | -34.41% |
※株式分割は考慮していませんのでご注意ください。
Page Top